Double maintains 2 strategies that include PRTA - Prothena Corp. Plc
Current Value
$12.271 Year Return
Current Value
$12.271 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAXF | -0.15% | $515.52M | 0.29% |
IBTP | 0.16% | $108.59M | 0.07% |
CNBS | 0.20% | $67.47M | 0.77% |
CORN | 0.37% | $51.34M | 0.2% |
EQLS | -0.38% | $4.77M | 1% |
GOVZ | -0.39% | $288.61M | 0.1% |
VTEB | -0.49% | $35.63B | 0.03% |
XMPT | -0.55% | $172.81M | 1.98% |
SGOV | -0.60% | $39.39B | 0.09% |
MUB | -0.66% | $39.42B | 0.05% |
IBMN | -0.70% | $473.20M | 0.18% |
MUNI | 0.76% | $1.81B | 0.35% |
CMF | 0.78% | $3.76B | 0.08% |
DUSB | 0.86% | $1.15B | 0.15% |
ZROZ | 0.87% | $1.57B | 0.15% |
CLOI | -0.92% | $1.02B | 0.4% |
ULST | 0.92% | $587.03M | 0.2% |
BCD | -0.92% | $249.09M | 0.3% |
MINT | -0.93% | $13.27B | 0.35% |
CANE | 0.99% | $11.05M | 0.29% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -22.35% | $86.92M | 0.59% |
VIXY | -21.49% | $195.31M | 0.85% |
BTAL | -16.33% | $404.97M | 1.43% |
BSSX | -13.98% | $75.46M | 0.18% |
UGA | -13.35% | $88.11M | 0.97% |
TPMN | -13.18% | $33.51M | 0.65% |
SMMU | -12.10% | $680.91M | 0.35% |
DBE | -12.01% | $54.58M | 0.77% |
CTA | -11.98% | $963.19M | 0.76% |
USL | -11.23% | $46.60M | 0.85% |
BSMW | -10.56% | $100.61M | 0.18% |
USCI | -10.39% | $236.09M | 1.07% |
OILK | -10.37% | $66.42M | 0.69% |
BNO | -10.25% | $95.40M | 1% |
BSMR | -10.19% | $232.31M | 0.18% |
DBO | -10.18% | $197.54M | 0.77% |
USDU | -9.90% | $213.46M | 0.5% |
COMT | -9.77% | $674.22M | 0.48% |
USO | -9.46% | $1.02B | 0.6% |
GSG | -9.16% | $1.04B | 0.75% |
Finnhub
Prothena Corporation plc Directors' Report and Consolidated Financial Statements For the Year Ended 31 December 2024 Registered...
SeekingAlpha
Prothena Corporation is advancing Birtamimab for AL amyloidosis. Learn why PRTA stock is risky with uncertain upcoming data and past trial disappointments.
Yahoo
Prothena ( NASDAQ:PRTA ) Full Year 2024 Results Key Financial Results Revenue: US$135.2m (up 48% from FY 2023). Net...
Yahoo
PRTA posts a wider-than-expected fourth-quarter loss. However, it reports encouraging pipeline progress for the quarter.
Yahoo
Prothena Corp PLC (PRTA) reports robust cash reserves and zero debt, setting the stage for pivotal clinical milestones in 2025.
Yahoo
Prothena (PRTA) delivered earnings and revenue surprises of -5.88% and 85.04%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DNLI | 48.21% | $1.97B | -33.88% | 0.00% |
DRI | 44.46% | $24.34B | +24.23% | 2.67% |
KRYS | 42.46% | $5.19B | +2.40% | 0.00% |
CLDX | 40.68% | $1.20B | -56.41% | 0.00% |
NWE | 38.35% | $3.55B | +14.25% | 4.51% |
CRNX | 38.09% | $3.12B | -27.92% | 0.00% |
NTLA | 37.69% | $736.01M | -73.88% | 0.00% |
RICK | 37.50% | $380.74M | -24.51% | 0.63% |
RYTM | 37.35% | $3.35B | +24.11% | 0.00% |
NXDT | 37.19% | $160.57M | -38.13% | 15.75% |
ASGN | 37.08% | $2.75B | -38.36% | 0.00% |
BEAM | 36.86% | $1.95B | -40.20% | 0.00% |
XNCR | 36.59% | $749.71M | -51.46% | 0.00% |
APGE | 36.57% | $2.22B | -42.57% | 0.00% |
RVMD | 36.43% | $6.57B | +11.62% | 0.00% |
ACLX | 36.42% | $3.60B | -2.06% | 0.00% |
ALT | 36.15% | $385.07M | -51.12% | 0.00% |
TRC | 36.03% | $425.86M | +3.19% | 0.00% |
NAVI | 35.86% | $1.29B | -25.84% | 5.09% |
ARWR | 35.73% | $1.75B | -54.89% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -13.08% | $23.69B | +24.42% | 1.08% |
GHI | -12.18% | $285.70M | -23.75% | 12.16% |
HUSA | -11.02% | $12.08M | -45.38% | 0.00% |
ZCMD | -10.34% | $32.28M | -3.40% | 0.00% |
OCFT | -8.79% | $246.52M | +195.15% | 0.00% |
PSQH | -8.43% | $98.27M | -53.36% | 0.00% |
DOGZ | -7.64% | $362.44M | +338.67% | 0.00% |
LITB | -7.55% | $36.77M | -56.14% | 0.00% |
CME | -7.27% | $95.61B | +25.13% | 3.98% |
K | -7.15% | $28.48B | +44.57% | 2.75% |
E | -7.02% | $47.07B | -2.86% | 6.76% |
LW | -6.95% | $7.60B | -49.23% | 2.67% |
STG | -6.35% | $28.45M | -43.90% | 0.00% |
PHG | -6.29% | $23.50B | +32.47% | 0.00% |
TCTM | -5.54% | $3.39M | -83.19% | 0.00% |
PULM | -5.36% | $24.32M | +282.76% | 0.00% |
CTAS | -5.18% | $82.94B | +20.80% | 1.79% |
NEUE | -4.79% | $58.51M | +7.28% | 0.00% |
SYPR | -4.78% | $37.07M | -2.42% | 0.00% |
UUU | -4.17% | $4.12M | +11.25% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PM | 0.01% | $246.80B | +73.59% | 3.38% |
IP | 0.03% | $28.07B | +36.69% | 3.47% |
CCI | -0.10% | $45.38B | -0.03% | 5.99% |
FMS | 0.13% | $14.61B | +30.43% | 2.58% |
TSN | 0.19% | $22.28B | +10.30% | 3.10% |
API | 0.23% | $293.58M | +57.65% | 0.00% |
CHD | -0.30% | $27.09B | +4.83% | 1.03% |
MDLZ | 0.33% | $87.77B | -2.74% | 2.69% |
CNC | -0.34% | $30.11B | -21.92% | 0.00% |
POAI | 0.36% | $10.96M | -33.04% | 0.00% |
CQP | 0.36% | $31.97B | +33.68% | 4.87% |
CAPR | -0.38% | $433.47M | +33.76% | 0.00% |
FSLR | 0.39% | $13.54B | -26.44% | 0.00% |
CEG | -0.40% | $63.17B | +8.41% | 0.72% |
TMUS | 0.40% | $304.51B | +63.96% | 1.15% |
CORT | -0.43% | $12.05B | +343.75% | 0.00% |
SBLK | -0.60% | $1.82B | -33.98% | 13.68% |
SAVA | 0.60% | $72.46M | -92.61% | 0.00% |
CI | -0.67% | $89.19B | -9.64% | 1.73% |
CASI | 0.68% | $28.95M | -40.98% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CPRJ | 59.74% | $48.46M | 0.69% |
RSPA | 54.06% | $290.25M | 0% |
XBI | 53.97% | $5.33B | 0.35% |
PBE | 50.65% | $233.11M | 0.58% |
BTC | 50.43% | $3.28B | 0.15% |
IBB | 48.54% | $5.92B | 0.45% |
GNOM | 46.20% | $53.29M | 0.5% |
IWC | 42.66% | $810.14M | 0.6% |
BBH | 41.84% | $368.79M | 0.35% |
GSSC | 41.71% | $512.57M | 0.2% |
IWM | 41.56% | $64.21B | 0.19% |
PINK | 41.46% | $141.43M | 0.5% |
VTWO | 41.45% | $10.91B | 0.07% |
FBT | 41.34% | $1.08B | 0.56% |
KAPR | 41.34% | $185.00M | 0.79% |
SMMV | 40.70% | $282.70M | 0.2% |
ARKG | 40.55% | $977.87M | 0.75% |
IWN | 40.41% | $10.97B | 0.24% |
IWO | 40.28% | $10.88B | 0.24% |
SCHA | 40.16% | $15.95B | 0.04% |